ICU Medical, Incorporated (ICUI) Shares Sold by ARP Americas LP

ARP Americas LP decreased its holdings in shares of ICU Medical, Incorporated (NASDAQ:ICUI) by 37.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,553 shares of the medical instruments supplier’s stock after selling 1,547 shares during the period. ARP Americas LP’s holdings in ICU Medical were worth $722,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in the stock. First Trust Advisors LP boosted its position in shares of ICU Medical by 436.0% during the 3rd quarter. First Trust Advisors LP now owns 108,440 shares of the medical instruments supplier’s stock valued at $30,661,000 after purchasing an additional 88,207 shares in the last quarter. Retirement Systems of Alabama boosted its holdings in ICU Medical by 8.5% in the third quarter. Retirement Systems of Alabama now owns 21,413 shares of the medical instruments supplier’s stock worth $6,055,000 after acquiring an additional 1,681 shares in the last quarter. Steward Partners Investment Advisory LLC boosted its holdings in ICU Medical by 815.4% in the third quarter. Steward Partners Investment Advisory LLC now owns 3,149 shares of the medical instruments supplier’s stock worth $890,000 after acquiring an additional 2,805 shares in the last quarter. Texas Permanent School Fund boosted its holdings in ICU Medical by 6.1% in the third quarter. Texas Permanent School Fund now owns 10,432 shares of the medical instruments supplier’s stock worth $2,950,000 after acquiring an additional 598 shares in the last quarter. Finally, Oakbrook Investments LLC boosted its holdings in ICU Medical by 35.8% in the third quarter. Oakbrook Investments LLC now owns 2,275 shares of the medical instruments supplier’s stock worth $643,000 after acquiring an additional 600 shares in the last quarter. Institutional investors own 73.34% of the company’s stock.

Several brokerages have issued reports on ICUI. TheStreet upgraded ICU Medical from a “c+” rating to a “b+” rating in a report on Monday, August 20th. ValuEngine upgraded ICU Medical from a “hold” rating to a “buy” rating in a report on Tuesday, October 2nd. Zacks Investment Research lowered ICU Medical from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 11th. Finally, BidaskClub upgraded ICU Medical from a “hold” rating to a “buy” rating in a report on Friday, September 28th.



In other news, Director Pfizer Inc sold 700,000 shares of the stock in a transaction that occurred on Monday, August 13th. The stock was sold at an average price of $284.35, for a total value of $199,045,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Thomas D. Mccall sold 11,133 shares of the stock in a transaction that occurred on Friday, August 24th. The stock was sold at an average price of $302.56, for a total value of $3,368,400.48. Following the completion of the sale, the vice president now directly owns 3,018 shares of the company’s stock, valued at $913,126.08. The disclosure for this sale can be found here. In the last quarter, insiders sold 711,920 shares of company stock worth $202,651,956. Corporate insiders own 12.50% of the company’s stock.

Shares of NASDAQ:ICUI opened at $253.36 on Friday. The company has a market capitalization of $5.44 billion, a price-to-earnings ratio of 45.90 and a beta of 0.41. ICU Medical, Incorporated has a 52-week low of $180.45 and a 52-week high of $321.70.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings results on Thursday, August 9th. The medical instruments supplier reported $2.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.82 by $0.84. The business had revenue of $360.46 million for the quarter, compared to analyst estimates of $337.60 million. ICU Medical had a return on equity of 12.78% and a net margin of 5.93%. The company’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.76 earnings per share. On average, equities analysts expect that ICU Medical, Incorporated will post 7.6 EPS for the current year.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Featured Article: What is Compound Annual Growth Rate (CAGR)?

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply